Comparing CTS and KKR is less a contest between peers than a study in contrasting market positioning. CTS Corporation is a mid-sized designer and manufacturer of sensors, actuators, and electronic components serving industrial, medical, aerospace, defense, and transportation markets. KKR & Co. Inc. is one of the world's largest alternative-asset managers, operating across private equity, credit, infrastructure, real estate, and insurance. This stock comparison will interest investors weighing a specialized industrial-technology turnaround against a diversified financial franchise, and traders evaluating relative performance and momentum across two very different risk and growth profiles. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
CTS Corporation designs and manufactures custom sensing, connectivity, and motion solutions for original equipment manufacturers (OEMs). Its diversified end markets—industrial, medical, and aerospace and defense—now account for roughly 60% of revenue, a deliberate shift away from its historical reliance on transportation. In recent market activity, CTS has shown notable strength, with the stock rising more than 40% year to date and trading near its 52-week high. Recent quarterly results showed sales growth of about 5% and record adjusted gross margin of 42.2%, supported by stronger free cash flow and a book-to-bill ratio above 1.0, indicating orders outpacing shipments. Management raised full-year sales and earnings guidance for a third consecutive time and completed the acquisition of Millar, a pressure-sensing business that expands its medical exposure. Sentiment has been supported by execution and margin expansion, though investors are watching for margin normalization and soft transportation demand.
KKR & Co. Inc. manages capital across private equity, credit, infrastructure, real estate, and insurance through its Global Atlantic platform. The firm's assets under management (AUM) have grown past $800 billion, up about 11% year over year, with record fee-related earnings and adjusted net income reported in recent quarters. KKR raised roughly $25 billion in new capital in a single recent quarter and holds a record pool of uninvested "dry powder" exceeding $140 billion. A major catalyst is the pending sale of USI Insurance Services, expected to add about $2 billion to adjusted net income upon closing. Despite these record operating results, the share price has lagged, trading meaningfully below its 2026 high. Market participants have focused on the lumpy, rate-sensitive nature of performance income, mixed portfolio marks, and downward revisions to consensus estimates, leaving the stock in a corrective phase even as its fee engine compounds. From what I see, the divergence between fundamentals and price is worth monitoring closely.
The two companies differ fundamentally in business model and risk profile. CTS is an asset-light manufacturer whose earnings depend on engineering execution, product mix, and end-market demand, with a market capitalization of roughly $1.7 billion. KKR is a capital-markets franchise of roughly $80 billion whose earnings combine recurring management fees with volatile performance income tied to investment exits and valuations. On growth drivers, CTS is levered to secular trends in medical sensing, defense spending, industrial automation, and data-center infrastructure, while KKR benefits from fundraising momentum, insurance growth, and a rebounding deal environment. Recent momentum diverges sharply: CTS is trending upward near highs, whereas KKR is consolidating well below its peak despite record earnings. Risk factors also contrast—CTS faces tariff exposure, transportation softness, and potential margin normalization, while KKR faces interest-rate sensitivity, valuation marks, and cyclicality in realization activity. Sector exposure is likewise distinct, with CTS concentrated in industrial technology and KKR diversified across financial services and private markets.
Based on observable factors, Tickeron's AI would likely favor CTS at present. The stock's technical posture—a sustained uptrend, proximity to 52-week highs, and strong relative momentum—combined with record margins, positive bookings, and repeated guidance raises reflects trend consistency and stability. In contrast, KKR exhibits strong fundamentals but weaker price momentum and less favorable near-term positioning. The AI's preference leans on momentum, trend persistence, and catalyst visibility rather than fundamental quality alone, and it is expressed as a probabilistic tilt rather than a definitive outcome. I’m watching this closely as the divergence plays out.
In my own research process, I often turn to Tickeron’s AI Trading Bots to test how systematic strategies align with current market conditions. These tools help surface automated approaches that match the momentum and risk profiles I’m evaluating, giving a practical layer to the fundamental and technical review. It is one of the resources I check when comparing names like these to see positioning across different timeframes and styles.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The 10-day RSI Oscillator for CTS moved out of overbought territory on October 30, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In 23 of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at 77%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTS as a result. In 51 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.
The Moving Average Convergence Divergence Histogram (MACD) for CTS turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 33 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
CTS moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for CTS crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +2.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTS advanced for three days, in 209 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
CTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. CTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.885) is normal, around the industry mean (3.856). P/E Ratio (24.012) is within average values for comparable stocks, (6.228). Projected Growth (PEG Ratio) (1.279) is also within normal values, averaging (0.930). Dividend Yield (0.003) settles around the average of (0.021) among similar stocks. P/S Ratio (2.945) is also within normal values, averaging (4.422).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of electronic components and sensors
Industry ElectronicComponents